Lund-based Neola Medical released its report for the third quarter last week. The company’s efforts to establish itself on the US market have begun to bear fruit and they have also presented promising clinical data that further strengthens their lung monitoring system Neola®. BioStock has reached out to CEO Hanna Sjöström to get her thoughts on the past quarter and to find out what happens next.

Read the article here: BioStock – Neola’s CEO: “The doors open for us in the US”

Read the report and the press release here: Neola Medical Q3 report 2023